| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/02/2001 | EP1095021A1 Quinoline derivatives |
| 05/02/2001 | EP1095011A1 Novel fluorescent lanthanide chelates |
| 05/02/2001 | EP1078926A9 Pyran derivatives |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | CN1293196A Dibenzylisoquinoline alkaloids and its preparing process and medicinal composition |
| 05/02/2001 | CN1065246C Process for preparation of salt of clavulanic acid |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | CA2016664C Indole derivative and method of production thereof |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029043A1 Ucs1025 derivatives |
| 04/26/2001 | WO2001029030A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/26/2001 | WO2001029027A1 2-alkoxybenzene derivatives |
| 04/26/2001 | WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19860972A1 Verfahren zur Herstellung derivatisierter Polymere A process for preparing derivatized polymers |
| 04/26/2001 | CA2387972A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/25/2001 | EP0864572B1 Crystal of hydrate and process for preparation thereof |
| 04/25/2001 | CN1292792A Microencapsulated lewis acid |
| 04/25/2001 | CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists |
| 04/24/2001 | US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
| 04/24/2001 | US6221894 Nodulisporic acid derivatives |
| 04/24/2001 | US6221892 Heterocyclic topoisomerase poisons |
| 04/24/2001 | US6221872 Debrominating a pyrrole; fusing the product with an amidine; condensing the product with a nucleophile; reducing and purifying |
| 04/24/2001 | US6221606 Energy transfer dye comprising a donor dye which absorbs ight and emits exitation energy, an acceptor dye the absorbs the excitation energy and fluoresces in response, and a linker linking the two dyes, at least one is a dibenzorhodamine dye |
| 04/24/2001 | US6220878 Optoelectronic module with grounding means |
| 04/19/2001 | WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/18/2001 | EP0934268A4 Process for preparing 2-azadihydroxybicyclo 2.2.1]heptane compounds and the l-tartaric acid salt of the compound |
| 04/18/2001 | CN1064684C Effective components of wild opium poppy and extracting process and product thereof |
| 04/17/2001 | US6218540 Process for preparing camptothecin |
| 04/17/2001 | US6218534 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218405 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 04/17/2001 | US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease |
| 04/17/2001 | US6218399 Modifying the 20 position of camptothecin to form a compound which is low toxicity used in cancer therapy |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/12/2001 | WO2001025241A2 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025215A2 Method for selectively dissociating cyclic carboxylic acid anhydrides |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | DE19947953A1 Verfahren zur selektiven Spaltung cyclischer Carbonsäureanhydride Process for the selective cleavage of cyclic anhydrides |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/11/2001 | EP1090009A2 Cell adhesion-inhibiting antinflammatory compounds |
| 04/11/2001 | EP1090008A1 Syntheses of a variety of lamellarin compounds and analogues |
| 04/11/2001 | EP1090007A2 Cinoxacin lanthanide chelates and their use as biomolecular probes |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them |
| 04/11/2001 | CN1064360C Fused imidazo [1,2-alpha] pyridines |
| 04/10/2001 | US6214865 Anticancer agent |
| 04/10/2001 | US6214862 Analyzing proteasome sensitivity proteolysis |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214846 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214836 Water soluble analogues of 20(S)-camptothecin |
| 04/10/2001 | US6214827 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001022964A1 Dopamine transporter inhibitors and their use |
| 04/05/2001 | WO2001022951A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 04/05/2001 | WO2001012602A8 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 04/05/2001 | CA2389049A1 Dopamine transporter inhibitors and their use |
| 04/05/2001 | CA2385490A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1087967A1 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides |
| 04/04/2001 | EP1087960A1 Macrocyclic analogs and methods of their use and preparation |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/04/2001 | CN1290253A Heterocyclic topoisomerase poisons |
| 04/03/2001 | US6211374 Water soluble, pyran-based photochromic compounds having carboxylate functionality |
| 04/03/2001 | US6211371 Reacting an aryl isonirile with an isoquinolin-1-one compound |
| 04/03/2001 | US6211369 Spiro compounds and the use thereof |
| 04/03/2001 | US6211366 Psychological, nervous system disorders |
| 04/03/2001 | US6211211 Anxiolytic, anticonvulsant and antiepileptic agent |
| 04/03/2001 | US6211193 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; antitumor and anticarcinogenic agents |
| 04/03/2001 | US6211192 Alkynyl-substituted camptothecins and process for their preparation |
| 04/03/2001 | CA2022486C 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones, a process for their preparation and their use as medicaments |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/29/2001 | WO2001021624A1 Compounds for fluorescence labeling |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP0842178B1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/28/2001 | EP0820446A4 Synthesis of bis-indolylmaleimides |
| 03/28/2001 | EP0741727B1 Process for isomerization of spirocyclic compounds with beta-aminocarboxyl and/or beta-aminocarbonyl systems |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/27/2001 | US6207832 Camptothecin analogs and methods of preparation thereof |
| 03/27/2001 | US6207679 Antimicrobial agents uses and compositions related thereto |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/27/2001 | US6207672 Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids |
| 03/27/2001 | CA2148822C Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |